Management of Malignant Pleural Effusion

Journal of Bronchology and Interventional Pulmonology

Volumn 22, Issue 3, 2015, Pages 215-225

  Shafiq, Majid ^a   Frick, Kevin D ^b   Lee, Hans ^c   Yarmus, Lonny ^c   Feller Kopman, David J ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cost effectiveness; malignant; pleural diseases; pleural effusion

Indexed keywords

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HUMAN; MALIGNANT PLEURA EFFUSION; MEDICARE; PLEURODESIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REPEAT PROCEDURE; THORACOCENTESIS; TUNNELED PLEURAL CATHETER; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; ECHOGRAPHY; ECONOMICS; FEMALE; INTERVENTIONAL ULTRASONOGRAPHY; MALE; PLEURAL EFFUSION, MALIGNANT; PNEUMOTHORAX; PRACTICE GUIDELINE; PROCEDURES; QUALITY OF LIFE; STANDARDS; UNITED STATES;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PNEUMOTHORAX; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; THORACENTESIS; ULTRASONOGRAPHY, INTERVENTIONAL; UNITED STATES;

EID: 84937786039     PISSN: 19446586     EISSN: 19488270     Source Type: Journal    
DOI: 10.1097/LBR.0000000000000192     Document Type: Article

References (39)

1. Villaneuva A. Management of malignant pleural effusions. In: Ernst A, Herth FJF, eds. Principles and Practice of Interventional Pulmonology. New York, NY: Springer; 2013:665-674.
2. Thomas JM, Musani AI. Malignant pleural effusions: a review. Clin Chest Med. 2013;34:459-471.
3. Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(suppl 2):ii32-ii40.
4. Rodriguez-Panadero F, Borderas Naranjo F, Lopez Mejias J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a postmortem series. Eur Respir J. 1989;2:366-369.
5. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. 2000;117:73-78.
6. Davies HE, Mishra EK, Kahan BC, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307:2383-2389.
7. Clive AO, Kahan BC, Hooper CE, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014;69:1098-1104.
8. Reddy C, Ernst A, Lamb C, et al. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011;139:1419-1423.
9. Putnam JB Jr. Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86:1992-1999.
10. Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010;13: 59-65.
11. Puri V, Pyrdeck TL, Crabtree TD, et al. Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg. 2012;94:374-379. discussion 79-80.
12. Light RW. Pleural Diseases, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.
13. Havelock T, Teoh R, Laws D, et al. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(suppl 2): ii61-ii76.
14. Gordon CE, Feller-Kopman D, Balk EM, et al. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med. 2010;170: 332-339.
15. Dresler CM, Olak J, Herndon JE II, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909-915.
16. Gonzalez AV, Bezwada V, Beamis JF Jr. et al. Lung injury following thoracoscopic talc insufflation: experience of a single North American center. Chest. 2010; 137:1375-1381.
17. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983;85:523-526.
18. Musani AI, Haas AR, Seijo L, et al. Outpatient management of malignant pleural effusions with smallbore, tunneled pleural catheters. Respiration. 2004;71: 559-566.
19. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129:362-368.
20. Fysh ET, Tremblay A, Feller-Kopman D, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144:1597-1602.
21. Muennig P. Cost-Effectiveness Analysis in Health: A Practical Approach, 2nd ed. San Francisco, CA: Jossey-Bass; 2008.
22. Overview of the Medicare and Medicaid programs. Health Care Financ Rev Stat Suppl. 1999;1-348.
23. Faddy M, Graves N, Pettitt A. Modeling length of stay in hospital and other right skewed data: comparison of phase-type, gamma and log-normal distributions. Value Health. 2009;12:309-314.
24. Gordis L. Epidemiology, 4th ed. Philadelphia, PA: Saunders; 2009.
25. Nafees B, Stafford M, Gavriel S, et al. Health state utilities for non small cell lung cancer. Health Qual Life Outcomes. 2008;6:84.
26. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11:733-741.
27. Consumer Price Index. Secondary Consumer Price Index. Available at: http://www.bls.gov/cpi/. Accessed April 20, 2014.
28. List of Diagnosis-related Groups (DRGs), FY 2011. Secondary List of Diagnosis-related Groups (DRGs), FY 2011. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/Downloads/DRGdesc11.pdf. Accessed April 20, 2014.
29. 2011 Short Stay Inpatient by DRG [PDF, 242KB]. Secondary 2011 Short Stay Inpatient by DRG [PDF, 242KB]. Available at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/Downloads/DRG11.pdf. Accessed April 20, 2014.
30. Physician Fee Schedule Search. Secondary Physician Fee Schedule Search. Available at: http://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx. Accessed April 20, 2014.
31. How to Use The Searchable Medicare Physician Fee Schedule (MPFS). Secondary How to Use The Searchable Medicare Physician Fee Schedule (MPFS). Available at: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/down loads/How-to-MPFS-Booklet-ICN901344.pdf. Accessed April 20, 2014.
32. Haas AR, Sterman DH, Musani AI. Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach. Chest. 2007; 132:1036-1041.
33. Hospital Outpatient Prospective Payment System. Secondary Hospital Outpatient Prospective Payment System. Available at: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLN Products/downloads/HospitalOutpaysysfctsht.pdf. Accessed April 20, 2014.
34. Waller TA. Level-II vs. level-III visits: cracking the codes. Fam Pract Manag. 2007;14:21-25.
35. Lee CP, Chertow GM, Zenios SA. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health. 2009;12: 80-87.
36. Evers S, Goossens M, de Vet H, et al. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005;21:240-245.
37. Boshuizen RC, Onderwater S, Burgers SJ, et al. The use of indwelling pleural catheters for the management of malignant pleural effusion-direct costs in a Dutch hospital. Respiration. 2013;86:224-228.
38. Penz ED, Mishra EK, Davies HE, et al. Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion. Chest. 2014;146: 991-1000.
39. Lorenzoni L, Belloni A, Sassi F. Health-care expenditure and health policy in the USA versus other high-spending OECD countries. Lancet. 2014;384: 83-92.